Despite Revenue Stability, Net Losses Continue; Strategic Focus on Dispositions and Debt Management
Revenue Surges but Net Losses Widen, Misses Analyst EPS Forecast
Significant Revenue Increase and Improved Losses Highlight Myriad Genetics' First Quarter Performance